Costs and benefits of the national cancer institute central institutional review board - Wikidata - awgldk - TriplyDB

Costs and benefits of the national cancer institute central institutional review board

Costs and benefits of the national cancer institute central institutional review board

http://www.wikidata.org/entity/Q33628809

about

Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform Toward a New Era of Trust and Transparency in Clinical Trials Institutional Review Boards: Purpose and Challenges Bringing the Common Rule into the 21st Century Data for cancer comparative effectiveness research: past, present, and future potential.The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations How local IRBs view central IRBs in the US How variability in the institutional review board review process affects minimal-risk multisite health services research.Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century"Accrual experience of National Cancer Institute Cooperative Group phase III trials activated from 2000 to 2007 Using central IRBs for multicenter clinical trials in the United States.Are central institutional review boards the solution? The National Heart, Lung, and Blood Institute Working Group's report on optimizing the IRB process.Role of academic medical centers in cell-based therapeutic clinical trials.The institutional review board is an impediment to human research: the result is more animal-based research.Ethics and privacy issues of a practice-based surveillance system: need for a national-level institutional research ethics board and consent standards Canada's new ethical guidelines for research with humans: a critique and comparison with the United States.Time required for institutional review board review at one Veterans Affairs medical center.Return of Genetic Research Results to Participants and Families: IRB Perspectives and Roles Protocol Development Program: A Novel Approach to Overcoming Barriers to Clinical Research.Central institutional review board review for an academic trial network Exclusion of Women of Childbearing Potential in Clinical Trials of Type 2 Diabetes Medications: A Review of Protocol-Based Barriers to Enrollment.Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials.National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.Analysis of start-up, retention, and adherence in ALS clinical trials Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.Ethics review of pediatric multi-center drug trials.Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.The Impact of Institutional Review Boards (IRBs) on Clinical Innovation: A Survey of Investigators and IRB Members.Efficient design of clinical trials and epidemiological research: is it possible?Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antib Single-Minded Research Review: The Common Rule and Single IRB Policy.A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.Time to institutional review board approval with local versus central review in a multicenter pragmatic trial.Proposed centralization of trial oversight stirs mixed reaction.Meeting the Challenge: The National Cancer Institute's Central Institutional Review Board for Multi-Site Research.Reviewing Human Subjects Research: Efficiency and Quality for the Military and Beyond.Prioritizing initiatives for institutional review board (IRB) quality improvement

P2860

Q27027684-5D11EFCA-183F-4255-995E-935AA0D274E4 Q27205111-6A97AB37-7C2B-415C-823A-CAA06ABEC1A2 Q28084996-3E0D1C99-6D6B-4934-BC6A-97A6A2AA474C Q28596070-01E7F781-9634-4F83-8317-B2B8350CB01D Q30416509-DE875739-31B7-4A64-9A82-61D88F9E9422 Q30557206-C85E7975-27C5-4723-8D58-D9D510922ABE Q31020546-94821A61-5167-4AF2-AE72-F1F694F21481 Q34240492-4F51D863-5DFB-4CEE-834B-B05C8BFAFD9E Q34458056-DEEB26FD-5B09-41A6-99D3-6A61A5C07D3E Q34488684-B20125DC-28B5-4C06-B4DE-8AEBC9FF0E51 Q34575907-7401B3B9-6178-4014-9CB3-D04F1938611B Q34713422-E186FCA9-822B-4C7D-9205-CF8AD1E46C64 Q34955599-C8F616F3-8CED-4358-A124-7BAC30CF12CA Q35081312-4EDE73CF-7577-470D-A9A2-E664825E751D Q35330399-72E2DCF3-49EB-4331-8562-C09EC22BDB9C Q35856764-C126DD1A-BFA9-43D7-8CE7-89DD2D6BD314 Q35923549-DB02213A-9C5D-45B3-9294-DCE015DD4216 Q36198371-3C088EC3-AF0A-4E09-9D99-DE98B1501A02 Q36709739-E682BAE8-3C6A-4C7D-9AD5-FEAAAE98FFDD Q36877011-A6C477A2-D71D-4A75-8156-3086920E365E Q36930276-FD609034-847A-415C-97C6-44A5B95E1339 Q36976212-07D90A5A-CE03-4132-A59B-BC780399558B Q37081102-9B5A82C8-F31E-40A0-B2C1-594167CCC584 Q37251679-C23F882A-1342-460D-9582-ACF43AAB25B6 Q38106002-8AE38269-9D91-4898-A074-9AB87B2C1FDC Q38263729-D859777E-A3F3-4091-B89D-45131603664D Q38377545-859BA0D7-EFA8-4C18-B1BD-7B41869D9D80 Q38632475-0058C5DC-3ABB-48EE-9389-2FF15ED5591C Q38817527-BCB6A799-1C50-4852-8903-54A632E2EDD1 Q38915822-ADF68B91-8E39-4160-A7AE-DA0D9A09DC39 Q39404844-DAC93479-450B-40FF-9435-819243429F56 Q40444551-34E37B85-089B-4446-B750-30A750D0C08C Q45069345-443E84CB-D92A-4AE3-ABA8-05928A25FA20 Q48595923-FB71D6F8-9828-4D62-9AD0-42EBEA55F4FC Q49559109-AF2A4171-81E3-4203-ADE8-3553408B5DD0 Q54327707-7FBD8C40-98C0-41FE-8853-314F1D58858E Q58271679-70DE7C59-837F-406E-915E-876A8A5DFC76

P2860

Costs and benefits of the national cancer institute central institutional review board

http://www.wikidata.org/entity/Q33628809

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Costs and benefits of the national cancer institute central institutional review board

@ast

Costs and benefits of the national cancer institute central institutional review board

@en

type

label

Costs and benefits of the national cancer institute central institutional review board

@ast

Costs and benefits of the national cancer institute central institutional review board

@en

prefLabel

Costs and benefits of the national cancer institute central institutional review board

@ast

Costs and benefits of the national cancer institute central institutional review board

@en

P1433

Q33628809-BAAE9032-3C23-4527-AE67-031B7627A0F0

P1476

Q33628809-967DF65E-CDBE-4CB8-804F-B420062D43B0

P2093

Q33628809-2773B1A3-505F-4412-BFB3-A7973B4010ED

Q33628809-2E879F0F-C6C6-409A-9C13-E60D22B046CC

Q33628809-D237817C-4F54-4D58-B719-FC1B943BE439

Q33628809-E204B54E-E0E3-4B9C-B420-58988D886B2B

Q33628809-E50F241A-CF62-45DD-87C3-5C88DB69517A

P2860

Q33628809-2D4205BA-E4BF-4D6D-A72D-8318ED822276

Q33628809-426EC6E9-9468-49CC-BAF2-4E5C003E9DCE

Q33628809-781F53AD-BF13-4F6C-A676-959C72273EF7

Q33628809-879EA481-6117-4F50-A5C2-2AFC3FC9BC4B

Q33628809-8900D4A8-85F5-4765-BA95-ABA1D94EA778

Q33628809-A7E73A30-4FAC-4A59-9006-E792318A16A1

Q33628809-B417FC97-F350-46C0-96A2-26D0D479BC2E

Q33628809-D5039DF4-F176-4699-BACB-B80CB8761D19

Q33628809-EF4D6226-3E61-42BC-A92E-16A82DF11992

P304

Q33628809-926D3BC2-CDB8-4466-BB13-ED3907B6C132

P31

Q33628809-0AAC9523-AB76-49B6-B936-E52BC9935D12

P356

Q33628809-C8FA9F02-01DE-4E90-8E70-2A022DB22D7E

P407

Q33628809-472BF28F-D4EC-450D-A3DC-689AA73C8C22

P433

Q33628809-BC564A65-B5EF-4FD5-94E5-6A251EB9521C

P478

Q33628809-4CCC6413-AEF5-4230-9CC0-E699258B33E5

P577

Q33628809-4BDB79AA-FE94-4AFE-909D-5DF780EE13B3

P698

Q33628809-1C05F0D3-FDD2-48F5-B6BB-A0A9406E1F62

P932

Q33628809-5527A1FF-37E3-428C-BB25-6F8626D5B49C

P356

JCO.2009.23.2470

P1433

Journal of Clinical Oncology

P1476

Costs and benefits of the national cancer institute central institutional review board

@en

P2093

Christine Murray

http://www.w3.org/2001/XMLSchema#string

Jacquelyn Goldberg

http://www.w3.org/2001/XMLSchema#string

Jeanne M Adler

http://www.w3.org/2001/XMLSchema#string

Jeffrey Abrams

http://www.w3.org/2001/XMLSchema#string

Todd H Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Breaking the camel's back: multicenter clinical trials and local institutional review boards.

A central institutional review board for multi-institutional trials.

Variability in institutional review board assessment of minimal-risk research.

How do institutional review boards apply the federal risk and benefit standards for pediatric research?

Economies of scale in institutional review boards.

Self-reported utilization of health care services: improving measurement and accuracy.

Development of clinical trials in a cooperative group setting: the eastern cooperative oncology group

Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

The cost of institutional review board procedures in multicenter observational research.

P304

662-666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.23.2470

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19841324

http://www.w3.org/2001/XMLSchema#string

P932

2816001

http://www.w3.org/2001/XMLSchema#string